HEY THREAD, THEY SOLD ANOTHER ONE IN EUROPE, CHECK YAHOO!!!!
Jasman, You called it again !!
Integrated Surgical Systems Increases Installed
Base of Robodoc Surgical System to Sixteen in
Europe
PR Newswire - June 22, 1998 19:57
RDOC %MTC %HEA V%PRN P%PRN
SACRAMENTO, Calif., June 22 /PRNewswire/ -- Integrated Surgical Systems, Inc.
(ISS) (Nasdaq: RDOC; EASDAQ), a leading developer of image-directed robotic
products for surgical applications, today announced the sale of its ROBODOC(R)
Surgical Assistant System (ROBODOC) to the Evangelisches Krankenhaus
Bethesda in Monchengladbach, Germany. This sale increases the installed base of
ROBODOC Systems in Europe to sixteen.
"This installation is strategically important because it is the first site for the all too
important Dusseldorf area, which is a major metropolitan area of industrial northern
Germany. The Bethesda clinic is located close to Holland where there is a waiting
period for patients to get orthopedic surgeries performed," said Dr. Ramesh Trivedi,
President and Chief Executive Officer of ISS."
Dr. Baranowski, Chief of Orthopedic Surgeries at the hospital, commented, "The use
of the ROBODOC System will further perfect the implant technique. As a result, our
patients will not only benefit from the best product based on the latest technology, but
also from the high accuracy and patient safety offered by the ROBODOC System.
This is expected to result in longer implant stability which will be of great benefit to
our patients."
The Company
Integrated Surgical Systems, Inc. develops, manufactures, markets and services
computer-controlled, image-directed robotic products for surgical applications. The
ROBODOC Surgical Assistant System (ROBODOC) consists of a surgical robot
and a computer work station, ORTHODOC(R), which utilizes the company's
proprietary software for preoperative surgical planning. The ROBODOC System has
been used to perform precise total hip replacement surgical procedures on more than
2,500 patients worldwide. ROBODOC is currently being marketed in Europe, and
ISS is expected to file for FDA approval in the U.S. this year. NeuroMate(TM), ISS'
neurosurgery product, is the first robotic technology for use in stereotactic brain
surgeries. ISS has installed seven NeuroMate systems in France and Japan which
have supported neurosurgery on more than 1,500 patients to date.
Except for the historical information contained herein, the matters discussed in this
news release are forward-looking statements that involve risks and uncertainties,
including the timely development and market acceptance of new products and
upgrades to existing products, the impact of competitive products and pricing, and
other risks detailed from time to time in the company's filings with the Securities and
Exchange Commission (SEC).
SOURCE Integrated Surgical Systems, Inc.
/NOTE TO EDITORS: ROBODOC(R) and ORTHODOC(R) are registered
trademarks of
Integrated Surgical Systems, Inc. NeuroMate(TM) is a trademark of Innovative
Medical Machines International, S.A.; For more information on Integrated
Surgical Systems via fax at no cost, please call 800-PRO-INFO, 908-544-2850
outside the U.S., ticker symbol RDOC/
/CONTACT: Ramesh C. Trivedi, Ph.D. President and Chief Executive Officer,
or Mark Winn, Vice President and Chief Financial Officer, both of Integrated
Surgical Systems, Inc., 916-646-3487; Ann Trunko, general information, or Kate
Rajeck, analyst contact, 415-986-1591, both of The Financial Relations Board/
(RDOC) |
